Move expands inoculation program as vaccination rates slow
US regulators on Monday authorized Pfizer and its partner BioNTech’s Covid-19 vaccine for use in children as young as 12, widening the country’s inoculation program even as vaccination rates have slowed significantly.
The vaccine has been available under an emergency use authorization (EUA) to people as young as 16 in the United States.
